Helsinn

Developer of pharmaceutical products focused on cancer and chronic diseases

placeLugano, Ticino, Switzerland calendar_todayFounded 1976 groups103 employees language helsinn.com

Social engagement

Social engagement: 26.2K social following, 6 posts in the last 12 months — around the industry typical range.

Investor mix

1 investor on record; lead investors include Oberland Capital.

Investor typeCountShare
Private equity1100%

Recent activity

25 Jun 2026
Event
MASCC26 Annual Meeting
23 Jun 2026
Event
BIO International Convention 2026
19 Jun 2026
Partnership
Recordati, Arrotex Pharmaceuticals, Rafa, and Helsinn Therapeutics (U.S.), Inc.
Coming soon